Obesity leads to T-cell dysfunction and increases depletion of T cells with a PD-1-positive phenotype in the adipose tissue and TME through leptin production, whereas ICI therapy inhibits T cells by uncoupling PD-1/PD-L1 binding. This evidence concerns the gene PDCD1 and obesity disorder.